Carson Wealth (CWM LLC)
TXMD icon

Carson Wealth (CWM LLC)’s TherapeuticsMD TXMD Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$40 Hold
20
– – ﹤0.01% 5612
2025
Q4 		$0 Hold
20
– – ﹤0.01% 5650
2025
Q3 		$0 Buy
+20
New +$22 ﹤0.01% 5556
2022
Q3 		– Sell
-42
Closed – – 4192
2022
Q2 		$0 Buy
42
+2
+5% +$19 ﹤0.01% 4107
2022
Q1 		$1K Hold
40
– – ﹤0.01% 3418
2021
Q4 		$1K Buy
+40
New +$1.2K ﹤0.01% 3390
2021
Q2 		$2K Hold
40
– – ﹤0.01% 2713
2021
Q1 		$2K Hold
40
– – ﹤0.01% 2713
2020
Q4 		$2K Hold
40
– – ﹤0.01% 2712
2020
Q3 		$2K Hold
40
– – ﹤0.01% 2711
2020
Q2 		$2K Hold
40
– – ﹤0.01% 2710
2020
Q1 		$2K Hold
40
– – ﹤0.01% 2710
2019
Q4 		$2K Hold
40
– – ﹤0.01% 2708
2019
Q3 		$2K Hold
40
– – ﹤0.01% 2708
2019
Q2 		$2K Hold
40
– – ﹤0.01% 2707
2019
Q1 		$2K Buy
40
+30
+300% +$7.94K ﹤0.01% 2703
2018
Q4 		$2K Hold
10
– – ﹤0.01% 1804
2018
Q3 		$3K Hold
10
– – ﹤0.01% 1479
2018
Q2 		$3K Buy
+10
New +$3.06K ﹤0.01% 1316

Other funds holding TXMD

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Carson Wealth (CWM LLC)'s TXMD Position: Q1 2026 in Review

Carson Wealth (CWM LLC) held its TherapeuticsMD (TXMD) position steady in Q1 2026 at 20 shares worth $40. The position accounts for ﹤0.01% of the portfolio, ranked #5612.

Carson Wealth (CWM LLC) first reported a position in TXMD in Q2 2018 and has held it in 19 quarters since. The position peaked at $3K in Q3 2018. 49 funds tracked by Wall St. Rank hold TXMD as of Q1 2026.

  • Carson Wealth (CWM LLC) held 20 shares of TherapeuticsMD worth $40 as of Q1 2026.
  • Carson Wealth (CWM LLC) left its TherapeuticsMD share count unchanged in Q1 2026.
  • TherapeuticsMD made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #5612 holding.
  • Carson Wealth (CWM LLC) first reported a position in TherapeuticsMD in Q2 2018 and has held it in 19 quarters since.
  • Carson Wealth (CWM LLC)'s TherapeuticsMD position peaked at $3K in Q3 2018.
  • 49 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.